Honz Pharmaceutical Co., Ltd. (SHE:300086)
China
· Delayed Price · Currency is CNY 9.06
+0.11 (1.23%)
Mar 10, 2026, 3:04 PM CST
Honz Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,123 | 2,230 | 2,642 | 2,799 | 3,906 | 2,529 | Upgrade
|
| Market Cap Growth | 84.52% | -15.57% | -5.63% | -28.34% | 54.45% | 6.84% | Upgrade
|
| Enterprise Value | 4,616 | 2,676 | 3,033 | 3,196 | 4,251 | 2,952 | Upgrade
|
| Last Close Price | 9.06 | 4.90 | 5.87 | 6.22 | 8.68 | 5.60 | Upgrade
|
| PE Ratio | - | - | 229.10 | - | 355.50 | 270.79 | Upgrade
|
| Forward PE | - | 36.32 | 36.32 | 36.32 | 36.32 | 36.32 | Upgrade
|
| PS Ratio | 9.47 | 4.72 | 3.57 | 5.22 | 4.67 | 2.74 | Upgrade
|
| PB Ratio | 3.84 | 1.91 | 1.92 | 2.07 | 2.51 | 1.58 | Upgrade
|
| P/TBV Ratio | 4.41 | 2.26 | 2.27 | 2.48 | 3.05 | 2.46 | Upgrade
|
| P/FCF Ratio | 270.48 | - | - | - | - | - | Upgrade
|
| P/OCF Ratio | 33.43 | 31.21 | 37.37 | 95.45 | 344.77 | - | Upgrade
|
| EV/Sales Ratio | 10.60 | 5.66 | 4.10 | 5.97 | 5.08 | 3.20 | Upgrade
|
| EV/EBITDA Ratio | - | - | 22.93 | - | 126.48 | 25.22 | Upgrade
|
| EV/EBIT Ratio | - | - | 55.30 | - | - | 44.10 | Upgrade
|
| EV/FCF Ratio | 302.77 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.45 | 0.44 | 0.36 | 0.43 | 0.38 | 0.39 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 3.79 | - | 15.09 | 5.31 | Upgrade
|
| Debt / FCF Ratio | 31.90 | - | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.44 | 0.34 | 0.26 | 0.23 | 0.22 | 0.23 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.43 | -4.22 | 2.70 | -3.25 | 9.93 | 3.10 | Upgrade
|
| Net Debt / FCF Ratio | 30.72 | -18.87 | -5.33 | -10.58 | -1.60 | -1.15 | Upgrade
|
| Asset Turnover | 0.22 | 0.23 | 0.33 | 0.23 | 0.33 | 0.38 | Upgrade
|
| Inventory Turnover | 1.07 | 1.06 | 1.47 | 1.46 | 2.05 | 2.38 | Upgrade
|
| Quick Ratio | 0.21 | 0.42 | 0.85 | 0.79 | 0.99 | 0.76 | Upgrade
|
| Current Ratio | 0.67 | 0.89 | 1.60 | 1.33 | 1.49 | 1.22 | Upgrade
|
| Return on Equity (ROE) | -16.80% | -17.65% | 0.38% | -13.61% | 0.67% | 1.25% | Upgrade
|
| Return on Assets (ROA) | -3.92% | -4.73% | 1.54% | -3.86% | -0.13% | 1.74% | Upgrade
|
| Return on Invested Capital (ROIC) | -8.10% | -9.51% | 0.71% | -8.25% | -0.14% | 2.57% | Upgrade
|
| Return on Capital Employed (ROCE) | -8.80% | -10.60% | 3.10% | -8.20% | -0.30% | 3.30% | Upgrade
|
| Earnings Yield | -4.61% | -9.70% | 0.44% | -6.70% | 0.28% | 0.37% | Upgrade
|
| FCF Yield | 0.37% | -0.94% | -2.53% | -1.06% | -5.34% | -12.51% | Upgrade
|
| Dividend Yield | - | - | - | - | - | 0.36% | Upgrade
|
| Payout Ratio | - | - | 211.14% | - | 370.22% | 241.72% | Upgrade
|
| Buyback Yield / Dilution | -0.58% | -1.34% | -0.10% | 0.08% | -0.29% | 0.23% | Upgrade
|
| Total Shareholder Return | -0.58% | -1.34% | -0.10% | 0.08% | -0.29% | 0.59% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.